Briefs: Sopori to host Community Day Nov 10, 2009
Vietnam veterans who served one day in-country can file for service connected disability compensation if they suffer from any of these diseases, which include Hairy Cell Leukemia (HCL), Parkinson s Disease and Ischemic heart disease. Membership in the American Legion is not a requirement to receive assistance. (Green Valley News & Sun, AZ)
Kauai veterans October news Oct 22, 2009
The illnesses affected by the recent decision are B cell leukemias, such as hairy cell leukemia; Parkinson s disease; and ischemic heart disease. The secretary s decision brings to 15 the number of presumed illnesses recognized by the Department of Veterans Affairs. (Lihue Garden Island, HA)
Healthcare? Schmelthcare! Oct 21, 2009
vnvet wrote on Oct 19, 2009 11:06 AM:" While your article is to be commended on its face, there are some inaccuracies. The recent addition of Parkinson's Disease, Ischemic Heart Disease and Hairy Cell Leukemia came about as a reult of a review of scientific studies done recently. The review is conduction by the Institute of Medicine, a subset of the National Institute of Health. The IOM releases their review "Agent Orange and Veterans: Update" every two years, and the 2008 study was released in... (McKinney Courier-Gazette, TX)
Experimental Drug Lets B Cells Live And Lymphoma Cells Die Oct 5, 2009
8, 2007) Survivors of a rare cancer called hairy cell leukemia are at an increased risk of Hodgkin lymphoma, non-Hodgkin lymphoma, and thyroid cancer, and at an increased risk of death from leukemia and. (July 31, 2007) Scientists have identified a protein that prevents the body's immune system from recognizing and attacking Hodgkin lymphoma cells. (Science Daily)
Novel Tumor Suppressor Discovered Aug 13, 2009
8, 2007) Survivors of a rare cancer called hairy cell leukemia are at an increased risk of Hodgkin lymphoma, non-Hodgkin lymphoma, and thyroid cancer, and at an increased risk of death from leukemia and. (Apr. (Science Daily)
Agent Orange Linked to Parkinson's, Heart Disease Jul 28, 2009
The committee also clarified that hairy cell leukemia belonged in the same category as CLL and lymphomas. In addition to Parkinson's and heart disease, there was "limited or suggestive evidence" of an association between the herbicides and laryngeal cancer as well as cancers of the lung, bronchus, trachea and prostate, multiple myeloma, AL amyloidosis (a blood disorder) and type 2 diabetes. (MEDLINEplus)
Limited data suggest possible association between Agent Orange exposure Jul 25, 2009
In response to a request for clarification by the U.S. Department of Veterans Affairs, the committee also affirmed that hairy cell leukemia is in the same category as chronic lymphocytic leukemia (CLL) and lymphomas. Previous reviews in the series found sufficient evidence to state that there is an association between herbicide exposure and increased risk for CLL and lymphomas. (EurekAlert!)
Key To Blood Cell Development Could Lead To New Treatments For Cancer May 3, 2009
ScienceDaily (May 2, 2009) A West Australian research team has made the world-first discovery a 'pied piper' molecule within blood cells, called Liar, that leads other molecules into the nucleus of the cell, and could offer a key in treating prostate, breast and colon cancers as well as leukemia. Uncovered by two research groups at the Western Australian Institute for Medical Research (WAIMR) led by Associate Professor Evan Ingley and Director Professor Peter Klinken, they have also identified... (Science Daily)
Merck-Seronos cladribine could face regulatory hurdles Apr 28, 2009
Merck-Seronos cladribine could face regulatory hurdles regarding the risk of malignancy seen in clinical trials to date, as well as overall market limitations due to a current pregnancy category D label that the drug carries in hairy cell leukemia, physicians told Pharmawire ... Cladribine (2-chlorodeoxyadenosine) is currently marketed as an intravenous infusion to treat hairy cell leukemia, an uncommon chronic B-cell lymphoproliferative disorder ... One study by Saven et al. in the journal... (FT.com -- Markets)
Genentech timeline Mar 14, 2009
1986: The FDA approves Roferon, a drug for hairy cell leukemia that Genentech licensed to Hoffmann-La Roche. 1990: Roche Holding Ltd., in a $2. (San Francisco Chronicle -- Business)
Kevin ArmstrongINSIDE COLLEGE BASKETBALL Feb 14, 2009
Diagnosed with Hairy Cell Leukemia, a slow-growing blood cancer, on July 3, the quiet 72-year-old was undergoing treatment across town at Community General Osteopathic Hospital. But his worries were with his wife, Shirley. (SportsIllustrated.CNN -- NCAA Basketball)
